Comprehensive Clinical Guide: Aspiration Therapy (AspireAssist)

1. Introduction and Overview

Aspiration Therapy, marketed under the trade name AspireAssist, represents a unique, minimally invasive, endoscopic approach to the treatment of Class II and Class III obesity. Unlike traditional bariatric surgeries that involve irreversible anatomical restructuring of the gastrointestinal tract (such as gastric bypass or sleeve gastrectomy), Aspiration Therapy functions as a reversible, device-based therapy aimed at reducing caloric intake through the controlled removal of a portion of the ingested meal.

The system gained FDA approval in 2016 for patients with a Body Mass Index (BMI) of 35.0 to 55.0 kg/m² who have failed to achieve or maintain weight loss with non-surgical weight loss therapy. It is designed to be used in conjunction with lifestyle counseling, emphasizing the development of healthy eating habits and the importance of thorough mastication.

2. Technical Specifications and Mechanism of Action

The AspireAssist system consists of three primary components: a silicone Gastrostomy Tube (A-Tube), a Skin-Port, and an external device known as the AspireAssist Connector.

The Mechanism

The core philosophy behind Aspiration Therapy is "caloric titration." By removing approximately 30% of the ingested meal before it enters the small intestine, the patient achieves a caloric deficit.

• Gastrostomy Tube: A flexible tube is placed via Percutaneous Endoscopic Gastrostomy (PEG).
• Skin-Port: A low-profile valve that sits flush against the skin of the abdomen, allowing for the connection of the aspiration device.
• The Aspiration Process: Approximately 20–30 minutes after a meal, the patient connects the device to the Skin-Port. The patient opens the valve, and the system uses a controlled siphon effect to empty the stomach contents into the toilet.

Technical Table: System Components

3. Clinical Indications and Patient Selection

Aspiration Therapy is not a first-line treatment for obesity. It is strictly indicated for a specific demographic of patients who require medical intervention but may not be candidates for, or may be hesitant toward, major bariatric surgery.

Inclusion Criteria

• Age: 22 years or older.
• BMI: 35.0 to 55.0 kg/m².
• Failure of Non-Surgical Therapy: Documentation of unsuccessful weight loss attempts via diet, exercise, or pharmacological intervention.
• Psychological Readiness: Patients must demonstrate a clear understanding of the device’s requirements, including the necessity of chewing food thoroughly (to prevent tube clogging).

Exclusion Criteria

• Eating disorders (e.g., bulimia, night eating syndrome).
• History of prior gastric surgery (potential for adhesions or anatomical distortion).
• Uncontrolled hypertension or severe cardiovascular disease.
• Pregnancy or lactation.
• Conditions that prevent the safe performance of endoscopy.

4. Pre-Operative Preparation

Preparation is critical for the success of Aspiration Therapy. Since the device requires active patient participation, the pre-op phase focuses on education and medical clearance.

1. Multidisciplinary Consultation: Evaluation by a bariatric surgeon, a registered dietitian, and a psychologist.
2. Endoscopic Assessment: An EGD (Esophagogastroduodenoscopy) is performed to rule out gastric ulcers, hiatal hernias, or other structural abnormalities.
3. Nutritional Counseling: Patients are trained on the "chew, chew, chew" protocol. Because the A-Tube has a specific diameter, food must be masticated to a semi-liquid consistency to avoid clogging.
4. Informed Consent: Patients must be fully briefed on the reality of the aspiration process and the commitment required for long-term maintenance.

5. The Procedure: Step-by-Step

The placement of the AspireAssist system is typically performed under conscious sedation in an outpatient setting.

• Step 1: Endoscopy: An upper endoscopy is performed to visualize the stomach and determine the optimal site for the PEG placement.
• Step 2: Transillumination: The physician transilluminates the abdominal wall to ensure the stomach is in direct contact with the abdominal wall, minimizing the risk of peritoneal contamination.
• Step 3: Access: A needle is introduced into the stomach under endoscopic visualization, followed by the insertion of a guidewire.
• Step 4: Dilation: The tract is dilated to accommodate the AspireAssist tube.
• Step 5: Placement: The A-Tube is pulled through the abdominal wall and secured. The Skin-Port is attached.
• Step 6: Verification: The device is tested for patency and secure fit. The entire procedure typically lasts 20–30 minutes.

6. Post-Operative Recovery and Protocol

Recovery from the placement procedure is generally rapid, with most patients returning to light activity within 48 hours.

• Immediate Post-Op: Monitoring for pain, fever, or signs of abdominal irritation.
• Stoma Care: Daily cleaning of the Skin-Port with mild soap and water.
• Dietary Progression: A liquid diet for the first 48 hours, transitioning to soft foods, and eventually regular food, provided it is chewed thoroughly.
• Follow-up: Frequent visits with the clinical team to monitor weight loss, assess the tube site, and provide ongoing behavioral counseling.

7. Potential Complications and Risks

While minimally invasive, Aspiration Therapy carries risks inherent to any endoscopic procedure and gastrostomy placement.

• Common Side Effects:
  • Mild abdominal pain or discomfort at the site.
  • Skin irritation or granulation tissue around the stoma.
  • Nausea or vomiting in the immediate post-placement phase.
• Serious Complications:
  • Peritonitis: If the stomach separates from the abdominal wall before the tract matures.
  • Gastric Ulceration: Localized irritation from the tube tip.
  • Infection: Cellulitis or abscess at the stoma site.
  • Device Failure: Clogging or breakage of the Skin-Port.

8. Alternative Treatments

Patients who do not meet the criteria for AspireAssist or who desire different outcomes may consider:
1. Intragastric Balloons: Temporary space-occupying devices.
2. Endoscopic Sleeve Gastroplasty (ESG): A non-surgical, suturing procedure to reduce stomach volume.
3. Sleeve Gastrectomy/Gastric Bypass: Permanent surgical options with more profound weight loss results.
4. Pharmacotherapy: GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) for weight management.

9. Frequently Asked Questions (FAQ)

1. Is Aspiration Therapy a form of bulimia?

No. Bulimia is a psychological eating disorder characterized by binge eating and purging. Aspiration Therapy is a medically supervised treatment for obesity where the aspiration is performed under strict protocols to achieve a controlled caloric deficit.

2. How much weight can I expect to lose?

Clinical trials have shown that patients using AspireAssist lost significantly more weight compared to those receiving lifestyle counseling alone. Average excess weight loss (EWL) is typically in the range of 12-15% over the first year.

3. Does the tube hurt?

Most patients report minimal pain after the initial healing period. The Skin-Port is low-profile and generally not noticeable under clothing.

4. Can I eat whatever I want?

No. The system is designed to remove a portion of the food, not to justify unhealthy eating. A balanced diet is still required for long-term health and weight maintenance.

5. What happens if I don't chew my food well?

If food particles are too large, they will clog the tube. This can lead to the need for clinical intervention to clear the blockage or replace the tube.

6. Is the procedure permanent?

The system is reversible. The tube can be removed during a simple, brief endoscopic procedure, and the stoma site will heal naturally.

7. How often do I have to "aspire"?

The protocol generally requires aspiration after each main meal (typically 3 times a day).

8. Does the insurance cover this?

Coverage varies significantly by region and insurance provider. It is essential to verify coverage for "Aspiration Therapy" specifically, as it is classified differently than traditional bariatric surgery.

9. What if the tube falls out?

If the tube is dislodged, the patient must contact their physician immediately to prevent the stoma from closing and to ensure the gastric site remains secure.

10. Can I exercise with the device?

Yes. Once the site is healed, patients are encouraged to engage in regular physical activity. The device does not restrict movement.

10. Clinical Conclusion

Aspiration Therapy offers a unique middle ground in the bariatric landscape. By providing a tool for caloric reduction that is both reversible and less invasive than surgery, it empowers patients to take an active role in their weight management journey. However, it requires a high degree of patient compliance, psychological stability, and a commitment to the "chew, chew, chew" philosophy. Physicians must perform rigorous patient selection to ensure the success and safety of this intervention.

Disclaimer: This guide is for educational purposes and reflects clinical standards as of the current medical literature. Always consult with a board-certified bariatric surgeon or gastroenterologist regarding individual patient care and the risks associated with any medical procedure.